Nel ASA's Strategic Pivot Confronts Legacy Asset Impairment Risk

Nel secures shareholder backing for its new hydrogen tech but faces a potential impairment charge on idle production lines, with its stock near 52-week lows amid market skepticism.

The unanimous shareholder backing secured at Nel ASA's recent annual meeting provides a clear mandate for management's growth strategy. Yet this formal stability is immediately tested by a looming financial challenge: a potential impairment charge on two idle production lines. As the Norwegian hydrogen specialist pushes forward with its next-generation technology, it must simultaneously address costly remnants of its past.

A Costly Technological Transition

Central to Nel's strategy is the industrialization of its new pressure alkaline platform, promising a footprint reduction of up to 80% and cost savings of 40-60% compared to previous systems. This aggressive shift, however, leaves behind substantial legacy assets. The company is currently reviewing the book value of two dormant 500-megawatt production lines for atmospheric alkaline electrolyzers at its Herøya site. The outcome of this review—whether to reactivate, permanently shutter, or sell the lines—remains undecided, but it risks triggering further non-cash impairments.

Such a charge would hit a balance sheet already under strain. For the full year 2025, Nel reported a net loss of NOK 1.27 billion, significantly driven by prior value adjustments. The company entered the second quarter with a liquidity buffer of approximately NOK 1.6 billion, capital earmarked to fund the ramp-up of its new platform. Initial investments for the first gigawatts of production capacity are estimated at around NOK 300 million before subsidies, scheduled for 2026 and 2027.

Market Skepticism Amid Operational Crosscurrents

Investor sentiment reflects deep-seated caution about this transition. The stock, trading at EUR 0.19, hovers just above its 52-week low of EUR 0.18 marked in early March. This skepticism is echoed by analyst ratings. The consensus average price target stands at NOK 2.09 with a "Sell" recommendation. Recent adjustments include Berenberg lowering its target from NOK 2.60 to NOK 2.30 (Hold) and Citigroup cutting from NOK 2.70 to NOK 2.40.

The core concern is the unpredictable conversion of orders into revenue. While order intake exploded by 364% to NOK 686 million in Q4 2025, revenue from customer contracts actually fell by 20% in the same period. The order backlog stood at a solid NOK 1.3 billion at the start of the year, but its realization timeline is unclear.

Shareholder Backing and Capital Allocation

At last Friday's digital AGM, shareholders approved all agenda items, granting management the stability to execute its industrial scaling plans. This formal clarity comes with a continued focus on reinvestment over returns. Trading ex-dividend on Monday, the payout amount was precisely zero, as previously communicated. Nel maintains it is not yet in a phase where ongoing profits justify a distribution, directing all available capital into infrastructure and R&D instead. The share price dipped 1.45% to EUR 0.19 on the day, aligning with its 50-day moving average.

All eyes now turn to April 22, when Nel will release its first-quarter 2026 report. This disclosure is critical on two fronts. It must show whether the strong order intake from late 2025 is finally translating into revenue growth. Equally important, it should provide concrete data on the financial fate of the idle Herøya assets, revealing the cost of leaving an old technology behind while betting everything on the new.